Condition: Endometrial Hyperplasia · Endometrial Cancer · Gynecologic Cancer · Sponsor: Vancouver Coastal Health Research Institute
This study protocol evaluates the use of hysteroscopic endomyometrial resection in women diagnosed with atypical endometrial hyperplasia or grade I endometrial cancer who have not responded to anti-hormone therapy. Patients in this study wish to preserve fertility.
This description comes directly from the study's public registry record.
Neeraj Mehra, MD · 604-875-5508 · neeraj.mehra@ubc.ca
Always discuss trial participation with your own doctor first.
| Vancouver General Hospital | Vancouver, British Columbia, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04362046